Researchers from the St. Louis College of Pharmacy recently examined how weight-based insulin dosing affected hypoglycemia in people with hyperkalemia (abnormally high potassium levels in the blood). The findings showed that when patients with acute hyperkalemia weighed less than 95 kg, weight-based insulin led to less hypoglycemia than standard dosing.
The study examined the charts of 132 patients, all of whom weighed less than 95 kg and had hyperkalemia. Participants were randomly selected. Hypoglycemic events were reduced from 27.3% in the standard dosing to 12.1% in the weight-based dosing group.
These findings were published in the Journal of Hospital Medicine on January 13, 2016